Trial intelligence / Profile preview

OTO-201 in pediatric AOMT

NCT02408796Phase 2Completed

Sponsor
Otonomy, Inc.
Start
Mar 2015
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ciprofloxacin in acute otitis media (AOM), sponsored by Otonomy, Inc.. Started Mar 2015; status: completed.

02

Drugs

ciprofloxacin
03

Conditions

acute otitis media (AOM)

Beyond the preview

Go deeper on NCT02408796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02408796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call